Differences in quinpirole-induced local cerebral glucose utilization between naive and sensitized rats

Brain Research

Volumn 964, Issue 2, 2003, Pages 295-301

  Carpenter, Toni L ^a   Pazdernik, Thomas L ^a   Levant, Beth ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Behavioral sensitization; D2 dopamine receptor; D3 dopamine receptor; Drug addiction; Obsessive compulsive disorder; Quinpirole; 14C 2 Deoxyglucose

Indexed keywords

CARBON 14; DEOXYGLUCOSE; GLUCOSE; QUINPIROLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN METABOLISM; BRAIN REGION; CONTROLLED STUDY; DOSE RESPONSE; DRUG SENSITIZATION; GLOBUS PALLIDUS; GLUCOSE UTILIZATION; LOCOMOTION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

EID: 0037469962     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)04115-X     Document Type: Article

References (37)

1. Angrist B. Psychosis induced by central nervous system stimulants and related drugs. Creese I. Stimulants: Neurochemical, Behavioral and Clinical Perspectives. 1983;1-30 Raven Press, New York.
2. Arnt J., Hyttel J., Perregaard J. Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats. Eur. J. Pharmacol. 133:1987;137-145.
3. Baxter L.R., Phelps M.E., Mazziotta J.C., Guze B.H., Schwartz J.M., Selin C.E. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Arch. Gen. Psychiatry. 44:1987;211-218.
4. Brog J.S., Salyapongse A., Deutch A.Y., Zahm D.S. The patterns of afferent innervation of the core and shell in the 'accumbens' part of the rat ventral striatum: immunohistochemical detection of retrogradely transported fluoro-gold. J. Comp. Neurol. 338:1993;255-278.
5. Charney D.S., Bremer J.D. The neurobiology of anxiety disorders. Charney D.S., Neslter E.J., Bunney B.S. Neurobiology of Mental Illness. 1999;494-517 Oxford University Press, New York.
6. Culver K.E., Szechtman H. Monoamine oxidase inhibitor sensitive site implicated in sensitization to quinpirole. Eur. J. Pharmacol. 339:1997;109-111.
7. 1 supersensitive rats. Psychopharmacology. 95:1988;81-85.
8. Di Chiara G. The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol. Depend. 38:1995;95-137.
9. Eilam D., Szechtman H. Biphasic effect of D-2 agonist quinpirole on locomotion and movements. Eur. J. Pharmacol. 161:1989;151-157.
10. 2-agonist quinpirole induces preservation of routes and hyperactivity but no preservation of movements. Brain Res. 490:1989;255-267.
11. Ellison G. Stimulant-induced psychosis, the dopamine theory of schizophrenia, and the habenula. Brain Res. Rev. 19:1994;223-239.
12. 2 receptor agonist administration to rats. Eur. J. Pharmacol. 338:1997;117-121.
13. Isaacson R.L. The Limbic System. 1982;Plenum Press, New York.
14. Jaffe J.H. Drug addiction and drug abuse. Gilman A.G., Rall T.W., Nies A.S., Taylor P. The Pharmacological Basis of Pharmacology. 1993;522-573 McGraw-Hill, New York.
15. 2-like dopamine receptors in rat brain. J. Pharmacol. Exp. Ther. 262:1992;929-935.
16. 3 dopamine receptors in the rat brain and pituitary gland: a quantitative autoradiographic study. J. Pharmacol. Exp. Ther. 264:1993;991-1001.
17. 3 dopamine receptor-selective doses of 7-OH-DPAT and nafadotride. Brain Res. 812:1998;193-199.
18. Orzi F., Morelli M., Fieschi C., Pontieri F.E. Metabolic mapping of the pharmacological and toxicological effects of dopaminergic drugs in experimental animals. Cerebrovasc. Brain Metab. Rev. 5:1993;95-121.
19. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd Edition :1986;Academic Press, Sydney.
20. Pierce R.C., Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. Rev. 25:1997;192-216.
21. 2 antagonist sulpride on glucose utilization in dopaminergic regions of the rat brain. J. Neurochem. 49:1987;631-638.
22. Pontieri F.E., Mainero C., Riccia M.L., Passarelli F., Orzi F. Functional correlates of repeated administration of cocaine and apomorphine in the rat. Eur. J. Pharmacol. 284:1995;205-209.
23. Post R.M., Contel N.R. Cocaine-induced behavioral sensitization: a model for recurrent manic illness. Perris C., Struwe G., Jansson B. Biological Psychiatry. 1981;746-749 Elsevier, Amsterdam.
24. Robinson T.E. The neural basis of drug craving and incentive-sensitization theory of addiction. Brain Res. Rev. 18:1993;247-291.
25. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 11:1986;157-198.
26. Rossi J. III. Sensitization induced by kindling and kindling-related phenomena as a model of multiple chemical sensitivity. Toxicology. 111:1996;87-100.
27. Segal D.S., Kuczenski R., Okuda C. Clorgyline-induced increases in presynaptic DA: changes in the behavioral and neurochemical effects of amphetamine using in vivo microdialysis. Pharmacol. Biochem. Behav. 42:1992;421-429.
28. 14C]deoxyglucose method for the measurement of the local cerebral glucose utilization: theory, procedure and normal value in the conscious and anesthetized rat. J. Neurochem. 28:1977;897-916.
29. Szechtman H., Talangbayan H., Eilam D. Environmental and behavioral components of sensitization induced by the dopamine agonist quinpirole. Behav. Pharmacol. 4:1993;405-410.
30. Szechtman H., Sulis W., Eilam D. Quinpirole induces compulsive checking behavior in rats: a potential animal model of obsessive-compulsive disorder (OCD). Behav. Neurosci. 112:1998;1475-1485.
31. 1-like receptor stimulation. J. Pharmacol. Exp. Ther. 278:1996;347-353.
32. 2 dopamine agonists differentially alter basal ganglia glucose utilization in rats with unilateral 6-hydroxydopamine substantia nigra lesions. J. Neurosci. 7:1987;2927-2935.
33. Tsai S.J., Huang Y.H., Chang L.S., Yang Y.C., Sim C.B. Alterations in local cerebral glucose utilization in rats after chronic amphetamine administration without subsequent challenge. Psychiatry Res. 57:1995;65-73.
34. Tsuruta K., Frey E.A., Grewe C.W., Cote T.E., Eskay R.L., Kebabian J.W. Evidence that LY 141865 specifically stimulates the D-2 dopamine receptor. Nature. 292:1981;463-466.
35. Van Hartesveldt C. Temporal and environmental effects on quinpirole-induced biphasic locomotion in rats. Pharmacol. Biochem. Behav. 58:1997;955-960.
36. Vanderschuren L.J.M.J., Kalivas P.W. Alterations in dopaminergic and glutaminergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology. 151:2000;99-120.
37. Wolf M.E. Addiction: making the connection between behavioral changes and neuronal plasticity in specific pathways. Mol. Interventions. 2:2002;146-157.